Biora Therapeutics, Inc. (BIOR)
USD 0.65
(9.59%)
USD 0.65
(9.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 4000.00 | 305 Thousand | 1.24 Million | 74.31 Million | 143.98 Million | 127.97 Million |
| Cost of Revenue | 555 Thousand | 907 Thousand | 1.43 Million | 93.43 Million | 100.49 Million | 92.07 Million |
| Gross Profit | -551 Thousand | -602 Thousand | -190 Thousand | -19.12 Million | 43.49 Million | 35.89 Million |
| Operating Expenses | 67.14 Million | 62.08 Million | 119.08 Million | 176.06 Million | 183.61 Million | 150.13 Million |
| Selling, General and Administrative Expenses | 37.3 Million | 38.03 Million | 73.29 Million | 128.32 Million | 120.21 Million | 101.42 Million |
| Research and Development Expenses | 29.83 Million | 24.04 Million | 45.78 Million | 47.74 Million | 63.4 Million | 48.71 Million |
| Other Expenses | - | 2.61 Million | 5.99 Million | -25.08 Million | - | - |
| Cost and Expenses | 67.14 Million | 62.08 Million | 119.08 Million | 269.5 Million | 284.1 Million | 242.21 Million |
| Operating Income | -67.14 Million | -61.78 Million | -117.83 Million | -195.18 Million | -140.11 Million | -114.23 Million |
| Interest Expense | 9.81 Million | 10.99 Million | 12.63 Million | 34.87 Million | 9.19 Million | 9.09 Million |
| Income Tax Expense | -90 Thousand | -420 Thousand | -119 Thousand | -37.53 Million | -706 Thousand | 5.25 Million |
| Earnings before Tax | -124.42 Million | -49.25 Million | -178.64 Million | -230.06 Million | -148.74 Million | -123.85 Million |
| Net Income | -124.11 Million | -48.83 Million | -178.52 Million | -192.52 Million | -148.03 Million | -129.1 Million |
| Earnings Per Share Basic | -7.87 | -6.40 | -46.42 | -86.30 | -80.17 | -119.71 |
| Earnings Per Share Diluted | -7.87 | -6.40 | -46.42 | -86.30 | -80.17 | -119.71 |
| Weighted Average Shares Outstanding | 15.77 Million | 7.63 Million | 3.84 Million | 2.23 Million | 1.84 Million | 1.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 15.77 Million | 7.63 Million | 3.84 Million | 2.23 Million | 1.84 Million | 1.07 Million |
| Gross Margin | -137.75 | -1.97 | -0.15 | -0.26 | 0.30 | 0.28 |
| EBIT Margin | -28.51 Thousand | -193.98 | -51.07 | -2.63 | -0.93 | -0.85 |
| Profit Margin | -31.02 Thousand | -160.10 | -143.16 | -2.59 | -1.03 | -1.01 |
| EBITDA | -114.05 Million | -37.35 Million | -164.56 Million | -106.18 Million | -135.44 Million | -110.16 Million |
| Earnings Before Tax Margin | -16.78 Thousand | -202.56 | -94.50 | -2.63 | -0.97 | -0.89 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 318 Thousand | 542 Thousand | 4000.00 | 872 Thousand | - | 2000.00 |
| Cost of Revenue | 110 Thousand | 105 Thousand | 555 Thousand | 117 Thousand | 125 Thousand | 166 Thousand |
| Gross Profit | 208 Thousand | 437 Thousand | -551 Thousand | 755 Thousand | -125 Thousand | -164 Thousand |
| Operating Expenses | 15.99 Million | 16.05 Million | 66.59 Million | 13.22 Million | 23.32 Million | 14.93 Million |
| Selling, General and Administrative Expenses | 8.28 Million | 9.05 Million | - | 7.1 Million | 12.77 Million | 8.95 Million |
| Research and Development Expenses | 7.7 Million | 7 Million | - | 6.11 Million | 10.54 Million | 5.98 Million |
| Other Expenses | 9.89 Million | 105 Thousand | -65.47 Million | -13.27 Million | -52.1 Million | -5000.00 |
| Cost and Expenses | 16.1 Million | 16.05 Million | 67.14 Million | 13.34 Million | 23.32 Million | 14.93 Million |
| Operating Income | -15.78 Million | -15.51 Million | -67.14 Million | -13.34 Million | -23.32 Million | -14.93 Million |
| Interest Expense | 711 Thousand | -2.75 Million | 9.81 Million | 1.84 Million | -2.59 Million | 2.7 Million |
| Income Tax Expense | -67 Thousand | 48 Thousand | -90 Thousand | -95 Thousand | 1000.00 | 4000.00 |
| Earnings before Tax | 6.39 Million | -4.14 Million | -124.42 Million | -15.72 Million | -73.45 Million | -17.8 Million |
| Net Income | 6.46 Million | -4.18 Million | -124.11 Million | -15.41 Million | -73.45 Million | -17.8 Million |
| Earnings Per Share Basic | 0.18 | -0.14 | - | -0.62 | -4.89 | -1.47 |
| Earnings Per Share Diluted | -0.04 | -0.14 | - | -0.62 | -4.89 | -1.47 |
| Weighted Average Shares Outstanding | 35.72 Million | 29.29 Million | 15.77 Million | 24.81 Million | 15.02 Million | 12.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 74.21 Million | 29.29 Million | 15.77 Million | 24.81 Million | 15.02 Million | 12.14 Million |
| Gross Margin | 0.65 | 0.81 | -137.75 | 0.87 | - | -82.00 |
| EBIT Margin | -49.30 | -28.63 | - | -15.17 | - | -7386.50 |
| Profit Margin | 20.33 | -7.73 | -31.02 Thousand | -17.68 | - | -8903.50 |
| EBITDA | -15.67 Million | -15.51 Million | - | -13.22 Million | -23.32 Million | -14.77 Million |
| Earnings Before Tax Margin | -49.64 | -28.63 | -16.78 Thousand | -15.30 | - | -7467.00 |
UMAX
HARB-B
RDGA
GGBBF
TPIPL-R
SPKL